Science magazine’s selection of Cancer Immunotherapy as the “Breakthrough of the Year” for 2013 confirms ACGT’s belief: that cell and gene therapy can help patients avoid the harsh affects of traditional cancer treatment and ultimately save patients’ lives.
“Oncologists, a grounded in reality bunch, say a corner has been turned and we won’t be going back, ” writes Jennifer Couzin-Frankel in the December issue.
We are proud of the progress of the ACGT colleagues mentioned in the article – Drs. June and Pardoll – and our many talented Fellows.